The "offering" is for "preferred" shares. As these are NOT
The "offering" is for "preferred" shares. As these are NOT traded on the open market, they do not dilute any of the ownership of the company.
The preferred shares will be purchased back by the company after 1 year - at a "preferred" price that could net you a minimum of 32% to a maximum of 112%. Not a bad return for the least risky investment in this company (ie: preferred shares get paid before common shares).
The company is making this very generous offer to existing shareholders only. For that reason, and because of some bullsh$t regulations (thank you again, obama!) the company is barred from "soliciting" the general public - hence the offer is right now by "word of mouth".
A small group of shareholders (about 30) met here on Long Island about 3 weeks ago to talk about this offering. There have been other meetings in other places as well. The company's staff has been calling existing shareholders on record and asking them to "spread the word."
Later today, John Sherman is getting together with a small group of shareholders on Long Island to finalize the offering with them.
Again, if interested, and you are an accredited investor ($1 million in assets not including personal residence), or know an accredited investor that you can tell about this offering, you can reach John at 732-766-7115.
For regulatory reasons (thanks again, obama!) the two top shareholders can't take 100% of the offering. Someone a year from now could complain that the deal was too sweet and that it wasn't offered to anyone else but the "big shots". I think it falls under "nepotism" rules.
Bottom line: By many other shareholders taking the remaining 30%, the argument that it was a preferential agreement only available to the big wigs is shot to pieces.
The "new company" is extremely careful about dotting its i's and crossing its t's when it comes to SEC oversight.
Godspeed.
12
Baltia Air Lines Inc (BLTA) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Epiclay™ Brings New Energy to Sculpting World Folks, if ever there was a time to break the mold, it’s now, and Ace of Clay’s got us covered with Epiclay™—a fresh take on polymer clay that’s turning heads in the sculpture circuit. Over four long years, Ace of Clay, a brand that's gathered a rather colorful following through captivating sculptures and detailed...
Continue Reading
Infrared Imaging: The Backbone of Future Tech Kinda wild how infrared imaging's become a hot topic in tech circles. With the market expected to jump from USD 9.2 billion in 2026 to a hefty USD 12.6 billion by 2031, averaging a 6.4% growth rate, there's plenty to chew on. Even if you ain't the analytical type, it ain't hard to spot where the money's flowing. Infrared's...
Continue Reading
Rethinking Beauty Industry's AI Obsession Here’s a breath of fresh air from the otherwise AI-obsessed beauty landscape: SACHEU, the brand that's been turning heads in cosmetics, decided to pair up with Limitless Labs. This partnership isn't about ceding control to machines but amplifying genuine human voices in their product development process. Yeah, it's a...
Continue Reading
Revolutionizing Film Financing The film industry has always been a tough nut to crack. Imagine trying to keep your creative baby yours without surrendering the crown jewels of intellectual property. Well, now, the cavalry with a fresh game plan has arrived, and both investors and filmmakers might be ready for another round. This isn't the typical PR fairytale; it's...
Continue Reading
When the Driver Disappears: Steps Forward Hit and run accidents can leave you feeling abandoned and unsure of what to do. In St. Tammany Parish, this scenario is all too familiar. Personal Injury Attorney Ross F. Lagarde cuts through the chaos, offering a clear path for those caught in this nightmare, explained in HelloNation's comprehensive guide. Prioritize Safety and...
Continue Reading
Revolutionizing the E-Commerce Landscape Wake up and smell the innovation, folks! SureDone is rolling out Taska AI, a tool that's set to declutter the chaotic world of enterprise marketplace listings. It's no bed of roses for sellers out there, dealing with diverse channel demands and post-submission hiccups. Taska AI steps in as the seasoned handyman these sellers...
Continue Reading
Oracle Steps into Healthcare's Payment Arena You ever try solving a puzzle with half the pieces missing? Well, that's exactly what healthcare orgs have been doing with their revenue cycles. Oracle (NYSE:ORCL) thinks it’s got the missing pieces. They've announced some slick AI capabilities to grease the wheels of healthcare revenue management. But hey, I've seen grand...
Continue Reading
The cosmos are back on the show menu at Florida Southern College, folks. Let's dig into what that means for history buffs and star gazers alike. We're talking about the big reopening of the college's Frank Lloyd Wright designed Planetarium—a space that's been gathering dust for far too long. Dive in with me to see why this is more than just a coat of paint on an old...
Continue Reading
BlueCollar Cloud Aligns with SuiteWorld 2026 If you thought the construction ERP space was just a dusty office in a backlot, think again. BlueCollar Cloud is strapping on its boots and diving into the heart of SuiteWorld 2026 with a platinum sponsorship. This isn't just a walk in the park—it's a strategic power move, aligning themselves smack-dab in the middle of...
Continue Reading
Navigating the Address Change Labyrinth Every time that welcome mat rolls out in a new spot, you're signing up for a mountain of paperwork. Sloth Move just painted a picture of the administrative mess awaiting those 1.8 million English households that decided 'new view, new digs' last year. Their analysis highlights why moving home means more than packing boxes—it's...
Continue Reading
Top 5 Most Recently Viewed Articles
Novo Nordisk A/S Securities Class Action Opportunity Investors who purchased securities of Novo Nordisk A/S (NYSE: NVO) between specific dates have a significant opportunity to engage in a class action lawsuit. This lawsuit is rooted in claims pertaining to misrepresentation of crucial details surrounding the company's clinical trial outcomes and announcements made by the...
Continue Reading
The Implications of the NFP Report on Fed Decisions This month’s jobs report is critical, particularly due to anticipated benchmark revisions to past employment figures. These revisions may indicate more than a million jobs could be adjusted, leading to discussions about a potential rate cut by the Federal Reserve. Key Expectations for the NFP Report Analysts forecast...
Continue Reading
Vegamour Unveils GRO+ Advanced Hair Growth Supplements Vegamour, a leader in plant-powered biotech dedicated to enhancing hair longevity, has recently announced a groundbreaking product: the GRO+ Advanced Hair Growth & Density Supplements. This new dual-pill system is designed to combat hair thinning through a unique internal approach that prioritizes health and wellness....
Continue Reading
Coalfire Pioneers ISO 42001 Certification for AI Governance Coalfire is leading the cybersecurity industry by becoming one of the first organizations accredited by the ANSI National Accreditation Board (ANAB) for the ISO/IEC 42001:2023 standard, dedicated to Artificial Intelligence governance. The Need for AI Governance As AI technologies continue to advance rapidly, the...
Continue Reading
Akeso's Groundbreaking Clinical Trial Results Akeso, Inc. (9926.HK) is thrilled to share significant breakthroughs from its Phase III clinical study of ivonescimab, a cutting-edge PD-1/VEGF bispecific antibody designed to treat non-small cell lung cancer (NSCLC). The study, known as HARMONi-2/AK112-303, has garnered attention following its publication in The Lancet, one...
Continue Reading
